Precipio PRPO
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Precipio (PRPO) Business Model and Operations Summary
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Key Insights
Precipio (PRPO) Core Market Data and Business Metrics
Latest Closing Price
$5.65Market Cap
$8.38 MillionAverage Daily Trade Volume
9,396 SharesPrice-Earnings Ratio
-1.93Total Outstanding Shares
1.50 Million SharesCEO
Mr. Ilan DanieliTotal Employees
57Dividend
No dividendIPO Date
July 18, 2000SIC Description
Laboratory Analytical InstrumentsPrimary Exchange
NASDAQHeadquarters
12325 Emmet St, Omaha, NE, 68164
Historical Stock Splits
If you bought 300 shares of PRPO before April 29, 2019, you'd have 1 share today.
| Execution Date | Split Amount |
|---|---|
| September 22, 2023 | 1-for-20 (Reverse Split) |
| April 29, 2019 | 1-for-15 (Reverse Split) |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-113,000 |
| Net Cash Flow From Financing Activities | $-329,000 |
| Net Cash Flow, Continuing | $-113,000 |
| Net Cash Flow From Financing Activities, Continuing | $-329,000 |
| Net Cash Flow From Investing Activities | $-223,000 |
| Net Cash Flow From Investing Activities, Continuing | $-223,000 |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Revenues | $18.53 Million |
| Basic Earnings Per Share | $-2.93 |
| Net Income/Loss | $-4.29 Million |
| Operating Expenses | $11.78 Million |
| Income/Loss From Continuing Operations Before Tax | $-4.29 Million |
| Benefits Costs and Expenses | $22.82 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $-4.29 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss | $-4.29 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Noncontrolling Interest | $0 |
| Equity Attributable To Parent | $12.09 Million |
| Inventory | $724,000 |
| Other Current Assets | $2.73 Million |
| Intangible Assets | $11.87 Million |
| Long-term Debt | $383,000 |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||